Angeles Therapeutics is a next generation cell and immune therapy company based on the technology licensed from the laboratory of its founder @PreetChaudhary. Angeles has developed a novel CAR-T and CAR-NK platforms that provide physiological TCR signaling and overcomes most of the limitations of current generation CAR-T. Most importantly, our platform is highly effective against solid tumors. Angeles has also developed one of the largest portfolio of CAR-T and CAR-NK in the world targeting more than 130 antigens covering cancer, infection and immune disorders. Our platform is fully compatible with autologous, allogeneic, universal and bispecific approaches. Angeles has recently entered a partnership with a global major pharmaceutical company and is looking for additional partnership opportunities for further development of its portfolio.
Company Details
- Founded
- -
- Address
- Los Angeles, Ca 91602, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://angelestherapeutics.com/
- HQ
- Los Angeles, CA
Angeles Therapeutics, Inc. Questions
Angeles Therapeutics, Inc.'s website is https://angelestherapeutics.com/
Angeles Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/angeles-therapeutics
Angeles Therapeutics, Inc.'s industry is
Biotechnology Research
Angeles Therapeutics, Inc.'s top competitors are
Bluewhale Bio,
4m Therapeutics Inc.,
Acorda Therapeutics, Inc.,
March Biosciences,
Nkilt Therapeutics, Inc.,
Rocket Pharmaceuticals,
Kiromic Biopharma, Inc.,
Siren Biotechnology,
Komo Biosciences,
Anim8 Llc.
Angeles Therapeutics, Inc.'s categories are Biotechnology Research
Angeles Therapeutics, Inc.'s founding year is 2018
